IBI: AT372; Tamara Krajnović***, naučni saradnik, Univerzitet u Beogradu, Institut za biološka istraživanja 'Siniša Stanković'; Polje: prirodno-matematičke i medicinske nauke; Period: 2020-2024;
eNauka profil: rp05322; ORCID: 0000-0002-6938-6154;
WOS indikatori: NR = 21; TC = 304; HIndex = 10;
eNauka WOS indikatori: NR = 26; TC = 317; HIndex = 10 ;
Lista A broj bodova: 40.50336 (618) 54.4%; Lista B broj bodova: 215.7540 (618) 6.5%; Lista C broj bodova: 0.000 (0) nan%; Lista A broj bodova kolaboracije: 0.000 (0) nan%; Lista B broj bodova kolaboracije: 0.000 (0) nan%;
Statistika svih rezultata
| Statistika | Ukupno | 2013-2024 | 2015-2024 | 2018-2024 | 2020-2024 |
|---|---|---|---|---|---|
| Broj rezultata | 21 | 19 | 18 | 14 | 7 |
| Broj citata | 304 | 264 | |||
| Broj M bodova | 57.00 | 57 | 57.00 | 57 | |
| Normirani broj citata | 246.04 | 215.75 | |||
| Normirani broj M bodova rezultata kategorije M21a++M21a+M21+M22+M23+M24 | 40.50 | 40.50 | 40.50 | 40.50 | |
| Normirani broj M bodova rezultata kategorije M11+M12+M13+M14+M41 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Normirani broj M bodova rezultata kategorije M11+M12+M13+M14+M41+M42 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Normirani broj M bodova rezultata kategorije M51 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Normirani broj M bodova rezultata kategorije M43+M44 | 0.00 | 0.00 | 0.00 | 0.00 |
Statistika rezultata nastalih u medunarodnim kolaboracijama
| Statistika | Ukupno | 2013-2024 | 2015-2024 | 2018-2024 | 2020-2024 |
|---|---|---|---|---|---|
| Broj rezultata sa 20 i više autora | 0 | 0 | 0 | 0 | 0 |
| Broj citata rezultata sa 20 i više autora | 0 | 0 | |||
| Broj M bodova rezultata M21a++M21a+M21+M22+M23 sa 20 i više autora | 0.00 | 0 | 0.00 | 0 | |
| Normirani broj citata rezultata sa 20 i više autora | 0.00 | 0.00 | |||
| Normirani broj M bodova rezultata M21a++M21a+M21+M22+M23 sa 20 i više autora | 0.00 | 0.00 |
Rezultati
| RB | IBI | Godina | Kat | Tip | Vrsta | Referenca | TC | TCP | BA | NBB | NTC | Naslov | Autori | 1. | AT372 | 2014 | E | EUROPEAN JOURNAL OF PHARMACOLOGY Vol. 740 (): # 683 - 689 (7), (DOI: 10.1016/j.ejphar.2014.06.009) OCT 5 2014WOS | 10 | 10 | 10 | 0 | 6.2500 | Novel inhibitors of macrophage migration inhibitory factor prevent cytokine-induced beta cell death | Vujicic M, Nikolic I, Krajnovic T, Cheng K, VanPatten S, He M, Stosic-Grujicic S, Stojanovic I, Al-Abed Y, Saksida T | 2. | AT372 | 2015 | E | JOURNAL OF INORGANIC BIOCHEMISTRY Vol. 153 (): # 315 - 321 (7), (DOI: 10.1016/j.jinorgbio.2015.09.006) DEC 2015WOS | 32 | 30 | 7 | 0 | 30.0000 | Ruthenium(II) p-cymene complex bearing 2,2′-dipyridylamine targets caspase 3 deficient MCF-7 breast cancer cells without disruption of antitumor immune response | Kaluderovic G, Krajnovic T, Momcilovic M, Stosic-Grujicic S, Mijatovic S, Maksimovic-Ivanic D, Hey-Hawkins E | 3. | AT372 | 2016 | E | PHARMACOLOGICAL RESEARCH Vol. 105 (): # 62 - 73 (12), (DOI: 10.1016/j.phrs.2016.01.011) MAR 2016WOS | 70 | 64 | 5 | 0 | 64.0000 | Versatile antitumor potential of isoxanthohumol: Enhancement of paclitaxel activity in vivo | Krajnovic T, Kaluderovic G, Wessjohann L, Mijatovic S, Maksimovic-Ivanic D | 4. | AT372 | 2017 | E | COATINGS Vol. 7 (7): #102 - (18), (DOI: 10.3390/coatings7070102) JUL 2017WOS | 13 | 11 | 5 | 0 | 11.0000 | Ti-SLActive and TiZr-SLActive Dental Implant Surfaces Promote Fast Osteoblast Differentiation | Kaluderovic M, Krajnovic T, Maksimovic-Ivanic D, Graf H, Mijatovic S | 5. | AT372 | 2017 | E | INORGANICS Vol. 5 (3): #56 - (13), (DOI: 10.3390/inorganics5030056) SEP 2017WOS | 2 | 2 | 7 | 0 | 2.0000 | (18-Crown-6)potassium(I) Trichlorido[28-acetyl-3-(tris-(hydroxylmethyl)amino-ethane)betulinic ester-N]platinum(II): Synthesis and In Vitro Antitumor Activity | Kaluderovic G, Bulatovic M, Krajnovic T, Paschke R, Zmejkovski B, Maksimovic-Ivanic D, Mijatovic S | 6. | AT372 | 2018 | E | MOLECULES Vol. 23 (10): #2463 - (16), (DOI: 10.3390/molecules23102463) OCT 2018WOS | 37 | 37 | 10 | 0 | 23.1250 | Anticancer and Differentiation Properties of the Nitric Oxide Derivative of Lopinavir in Human Glioblastoma Cells | Basile M, Mazzon E, Krajnovic T, Draca D, Cavalli E, Al-Abed Y, Bramanti P, Nicoletti F, Mijatovic S, Maksimovic-Ivanic D | 7. | AT372 | 2018 | E | NANOMATERIALS Vol. 8 (5): #322 - (16), (DOI: 10.3390/nano8050322) MAY 2018WOS | 28 | 25 | 8 | 0 | 20.8333 | Drug Delivery System for Emodin Based on Mesoporous Silica SBA-15 | Krajnovic T, Maksimovic-Ivanic D, Mijatovic S, Draca D, Wolf K, Edeler D, Wessjohann L, Kaluderovic G | 8. | AT372 | 2019 | E | MOLECULAR CARCINOGENESIS Vol. 58 (8): # 1362 - 1375 (14), (DOI: 10.1002/mc.23020) AUG 2019WOS | 18 | 18 | 11 | 0 | 10.0000 | Senescence as a main mechanism of Ritonavir and Ritonavir-NO action against melanoma | Paskas S, Krajnovic T, Basile M, Dunderovic D, Cavalli E, Mangano K, Mammana S, Al-Abed Y, Nicoletti F, Mijatovic S, Maksimovic-Ivanic D | 9. | AT372 | 2019 | E | FOOD AND CHEMICAL TOXICOLOGY Vol. 129 (): # 257 - 268 (12), (DOI: 10.1016/j.fct.2019.04.046) JUL 2019WOS | 19 | 17 | 8 | 0 | 14.1667 | The hop-derived prenylflavonoid isoxanthohumol inhibits the formation of lung metastasis in B16-F10 murine melanoma model | Krajnovic T, Draca D, Kaluderovic G, Dunderovic D, Mirkov I, Wessjohann L, Maksimovic-Ivanic D, Mijatovic S | 10. | AT372 | 2019 | E | EXPERIMENTAL CELL RESEARCH Vol. 380 (2): # 159 - 170 (12), (DOI: 10.1016/j.yexcr.2019.04.028) JUL 15 2019WOS | 9 | 8 | 8 | 0 | 6.6667 | The synthetic tubulysin derivative, tubugi-1, improves the innate immune response by macrophage polarization in addition to its direct cytotoxic effects in a murine melanoma model | Draca D, Mijatovic S, Krajnovic T, Pristov J, Dukic T, Kaluderovic G, Wessjohann L, Maksimovic-Ivanic D | 11. | AT372 | 2019 | E | ANTICANCER RESEARCH Vol. 39 (10): # 5403 - 5415 (13), (DOI: 10.21873/anticanres.13734) OCT 2019WOS | 5 | 3 | 6 | 0 | 3.0000 | Synthetic Tubulysin Derivative, Tubugi-1, Against Invasive Melanoma Cells: The Cell Death Triangle | Draca D, Mijatovic S, Krajnovic T, Kaluderovic G, Wessjohann L, Maksimovic-Ivanic D | 12. | AT372 | 2019 | E | ARCHIVES OF BIOLOGICAL SCIENCES Vol. 71 (2): # 347 - 356 (10), (DOI: 10.2298/ABS190305017C) 2019WOS | 0 | 0 | 6 | 0 | 0.0000 | Recasting as a booster of Ag-Pd alloy cytotoxicity: induction of cell senescence prior to mass cell death | Cairovic A, Stanimirovic D, Krajnovic T, Dojcinovic B, Maksimovic V, Cvijovic-Alagic I | 13. | AT372 | 2022 | M21a | E | Article | MATERIALS Vol. 15 (14): #5028 - (13), (DOI: 10.3390/ma15145028) JUL 2022WOS | 9 | 5 | 8 | 10.0000 | 4.1667 | Anticancer Potential of Xanthohumol and Isoxanthohumol Loaded into SBA-15 Mesoporous Silica Particles against B16F10 Melanoma Cells | Krajnovic T, Pantelic N, Wolf K, Eichhorn T, Maksimovic-Ivanic D, Mijatovic S, Wessjohann L, Kaluderovic G | 14. | AT372 | 2022 | M21 | E | Article | STEM CELL REVIEWS AND REPORTS Vol. 18 (6): # 2028 - 2044 (17), (DOI: 10.1007/s12015-021-10288-7) AUG 2022WOS | 26 | 19 | 14 | 3.3333 | 7.9167 | Mesenchymal Stem Cells From Mouse Hair Follicles Reduce Hypertrophic Scarring in a Murine Wound Healing Model | Li H, Ziemer M, Stojanovic I, Saksida T, Maksimovic-Ivanic D, Mijatovic S, Djmura G, Gajic D, Koprivica I, Krajnovic T, Draca D, Simon J, Lethaus B, Savkovic V | 15. | AT372 | 2022 | M21 | E | Article | NANOMATERIALS Vol. 12 (8): #1331 - (18), (DOI: 10.3390/nano12081331) APR 2022WOS | 10 | 9 | 8 | 6.6667 | 7.5000 | Combined Action of Hyper-Harmonized Hydroxylated Fullerene Water Complex and Hyperpolarized Light Leads to Melanoma Cell Reprogramming In Vitro | Markelic M, Draca D, Krajnovic T, Jovic Z, Vuksanovic M, Koruga D, Mijatovic S, Maksimovic-Ivanic D | 16. | AT372 | 2023 | M21 | E | Article | MICROMACHINES Vol. 14 (12): #2152 - (24), (DOI: 10.3390/mi14122152) DEC 2023WOS | 4 | 1 | 10 | 5.0000 | 0.6250 | The Second Derivative of Fullerene C60 (SD-C60) and Biomolecular Machinery of Hydrogen Bonds: Water-Based Nanomedicine | Matija L, Stankovic I, Puric M, Milicic M, Maksimovic-Ivanic D, Mijatovic S, Krajnovic T, Gordic V, Koruga D, Zhang Y | 17. | AT372 | 2024 | M21 | E | Article | CHEMMEDCHEM Vol. 19 (2): # - (17), (DOI: 10.1002/cmdc.202300506) JAN 15 2024WOS | 3 | 2 | 7 | 8.0000 | 2.0000 | Carboranes as Potent Phenyl Mimetics: A Comparative Study on the Reversal of ABCG2-Mediated Drug Resistance by Carboranylquinazolines and Their Organic Isosteres | Stockmann P, Kuhnert L, Krajnovic T, Mijatovic S, Maksimovic-Ivanic D, Honscha W, Hey-Hawkins E | 18. | AT372 | 2024 | M21 | E | Article | SCIENTIFIC REPORTS Vol. 14 (1): #30488 - (18), (DOI: 10.1038/s41598-024-81414-x) DEC 16 2024WOS | 4 | 0 | 14 | 3.3333 | 0.0000 | Re-design and evaluation of diclofenac-based carborane-substituted prodrugs and their anti-cancer potential | Selg C, Gordic V, Krajnovic T, Buzharevski A, Laube M, Kazimir A, Lönnecke P, Wolniewicz M, Sárosi M, Schädlich J, Pietzsch J, Mijatovic S, Maksimovic-Ivanic D, Hey-Hawkins E | 19. | AT372 | 2024 | M22 | E | Article | MOLECULAR BIOLOGY REPORTS Vol. 51 (1): #218 - (13), (DOI: 10.1007/s11033-023-09093-x) DEC 2024WOS | 5 | 3 | 8 | 4.1667 | 2.5000 | Anoikis and cancer cell differentiation: novel modes of shikonin derivatives anticancer action in vitro | Bovan D, Krajnovic T, Vukovic N, Vukic M, Mijatovic S, Tanic N, Arsenijevic N, Maksimovic-Ivanic D | 20. | AT372 | 2025 | E | CHEMMEDCHEM Vol. 20 (11): # - (14), (DOI: 10.1002/cmdc.202500084) JUN 2 2025WOS | 0 | 0 | 13 | 0 | 0.0000 | Advances in Diclofenac Derivatives: Exploring Carborane-Substituted N-Methyl and Nitrile Analogs for Anticancer Therapy | Selg C, Schuster R, Kazimir A, Lönnecke P, Wolniewicz M, Schädlich J, Laube M, Pietzsch J, Gordic V, Krajnovic T, Mijatovic S, Maksimovic-Ivanic D, Hey-Hawkins E | 21. | AT372 | 2025 | E | BIOORGANIC CHEMISTRY Vol. 164 (): #108894 - (13), (DOI: 10.1016/j.bioorg.2025.108894) SEP 2025WOS | 0 | 0 | 8 | 0 | 0.0000 | On the tumor cell growth limiting potential of newly synthesized acridine-1,8-dione derivatives | Lazic A, Mihajlovic E, Kapavarapu R, Dordevic I, Krajnovic T, Maksimovic-Ivanic D, Mijatovic S, Trisovic N |
|---|
27. 04. 2026.; 00:05:59; Trajanje procesiranja: 0.017 s
Legenda:
RB - redni broj rezultata
IBI - identifikacioni broj istraživača
Godina - godina u kojoj je rezultat publikovan (isključivo sa kompletnom paginacijom)
Kat - kategorija rezulata
Tip - tip rezultata (teorijski, simulacioni ili eksperimentalni)
Vrsta - vrsta rezultata
Referenca - referenca rezultata (bez autora i naslova rezultata) sa direktnim linkom na rezultat (ako ima DOI broj), sa linkom na zapis u eNauci ili WOS
TC - ukupan broj citata rezulata na dan 31. 1. 2026. godine
TCP - ukupan broj citata rezultata u periodu 2015-2024
BA - broj autora na rezultatu
NBB - normirani broj bodova rezultata
NTC - normirani broj citata rezultata u periodu 2015-2024
Naslov - naslov rezultata
Autori - spisak svih autora ili najviše prvih 30 autora
Primer:
Primer normiranja broja M poena i broja citata ostvarenih na jednom rezultatu: eksperimentalni rad sa 11 autora u časopisu kategorije M21a+ koji je publikovan 2020. godine, citiran je 65 puta, od čega 55 puta u periodu 2015-2024. godine.
Normirani broj M poena koje istraživač ostvaruje na rezultatu je 20/(1+0.2*(11-10))=16.6667 a normirani broj citata je 55/(1+0.2*(11-10))=45.8333.
Ukupan broj ostaverinih bodova utvrđuje se na naznačenom periodu za sabiranje normiranih M poena svakog istraživača i u periodu za određivanje ukupnog broja normiranih citata (2015-2024).